15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents
- PMID: 15247739
- DOI: 10.1097/01.ju.0000130510.28768.f5
15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents
Abstract
Purpose: We assessed the success of retrograde placement of indwelling ureteral stents in the management of ureteral obstruction due to extrinsic compression.
Materials and methods: Between July 1987 and December 2002 adequate followup was available for 101 patients who underwent primary retrograde ureteral stenting for extrinsic ureteral obstruction. Mean age at presentation was 61.4 years (range 33 to 90). Chart review was performed on all patients for primary diagnosis, symptomatology, degree of hydronephrosis, creatinine levels (baseline, treatment and posttreatment), location of compression, size and number of stents used, progression to percutaneous nephrostomy tube (PNT), stent failure, days to stent failure, post-stent therapy and status at last followup.
Results: Mean length of followup was 11 months (range 1 to 127). In 101 patients 138 ureteral units (UU) were stented. Total stent failure occurred in 41 (40.6%) patients and 58 (42.0%) UU. A total of 40 (29.0%) UU required PNTs at a mean of 40.3 days (range 0 to 330) with 18 PNTs placed in less than 1 week. Cases of stent failure that did not undergo PNT placement included 18 (13.0%) UU at a mean of 52.4 days (range 3 to 128). A total of 90 (89.1%) patients had metastatic cancer at stenting with 32.2% dead at 5.8 months (range 1 to 32). Univariate and multivariate analyses identified cancer diagnosis, baseline creatinine greater than 1.3 mg/dl and post-stent systemic treatment as predictors of stent failure. Proximal location of compression and treatment creatinine greater than 3.11 mg/dl were marginal predictors of failure on univariate analysis, while proximal location of obstruction was also marginally significant on multivariate analysis. No predictors were identified for early stent failure (less than 1 week).
Conclusions: At almost 1 year followup stent failure due to extrinsic compression occurred in nearly half of treated patients. Analysis of data revealed a diagnosis of cancer, baseline mild renal insufficiency and metastatic disease requiring chemotherapy or radiation as predictors of stent failure. Managing extrinsic compression by retrograde stenting continues to be a practical but guarded decision and should be tailored to each patient.
Comment in
-
Catheters, stents and nephrostomy tubes. Are they necessary and do they work?J Urol. 2004 Aug;172(2):434. doi: 10.1097/01.ju.0000132845.99535.ee. J Urol. 2004. PMID: 15247697 No abstract available.
Similar articles
-
Predicting the success of retrograde stenting for managing ureteral obstruction.J Urol. 2001 Nov;166(5):1746-9. J Urol. 2001. PMID: 11586215
-
Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.Urology. 2007 Nov;70(5):846-50. doi: 10.1016/j.urology.2007.07.008. Urology. 2007. PMID: 18068437
-
The management of malignant ureteral obstruction treated with ureteral stents.J Urol. 2005 Dec;174(6):2125-8. doi: 10.1097/01.ju.0000181807.56114.b7. J Urol. 2005. PMID: 16280741
-
Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.J Urol. 2009 Dec;182(6):2613-7. doi: 10.1016/j.juro.2009.08.040. J Urol. 2009. PMID: 19836807 Review.
-
Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.J Urol. 2008 Aug;180(2):444-50. doi: 10.1016/j.juro.2008.04.008. Epub 2008 Jun 11. J Urol. 2008. PMID: 18550089 Review.
Cited by
-
The full metallic double-pigtail ureteral stent: Review of the clinical outcome and current status.Indian J Urol. 2015 Jan-Mar;31(1):8-14. doi: 10.4103/0970-1591.134232. Indian J Urol. 2015. PMID: 25624569 Free PMC article. Review.
-
Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies.World J Urol. 2014 Jun;32(3):729-36. doi: 10.1007/s00345-013-1143-y. Epub 2013 Aug 10. World J Urol. 2014. PMID: 23933664
-
Role of ureteric stents in relieving obstruction in patients with obstructive uropathy.Urol Ann. 2013 Jul;5(3):148-51. doi: 10.4103/0974-7796.115731. Urol Ann. 2013. PMID: 24049375 Free PMC article.
-
Drug-eluting metallic stents in urology.Indian J Urol. 2014 Jan;30(1):8-12. doi: 10.4103/0970-1591.124198. Indian J Urol. 2014. PMID: 24497674 Free PMC article. Review.
-
Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.Eur Radiol. 2019 Feb;29(2):628-635. doi: 10.1007/s00330-018-5560-6. Epub 2018 Jul 4. Eur Radiol. 2019. PMID: 29974220 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources